GO:1990630 IRE1-RACK1-PP2A complex Guide

GO:1990630, the IRE1-RACK1-PP2A complex, is a cellular-component ontology term that defines a specific ternary protein assembly built from IRE1 (inositol-requiring enzyme-1, gene ERN1), RACK1 (receptor of activated protein kinase C 1, gene GNB2L1) and the protein phosphatase 2A (PP2A) holoenzyme. The defining architectural feature is that RACK1 acts as an adaptor, bridging a physical interaction between IRE1 and PP2A rather than merely co-occupying the same compartment. This distinguishes the term from generic ER-membrane or phosphatase-complex annotations and makes it a precise target for interaction proteomics and imaging studies. For researchers, the term matters because it converts a loosely described signaling relationship into a defined molecular entity that can be perturbed genetically. Scaffold proteins such as RACK1 are increasingly recognized as decision nodes that determine which substrates a phosphatase encounters, and BAP1-complex studies have illustrated how scaffold-dependent assemblies can reshape biological outcomes in cancer and development. The IRE1-RACK1-PP2A complex therefore provides a tractable entry point for asking how ER-associated signaling is attenuated or redirected by dephosphorylation. Mechanistic work on multi-subunit assemblies in other systems, including SMC complexes and chromatin remodelers, has shown that assembly order and nucleotide state strongly influence function [1,6]. Applying the same logic to GO:1990630 means asking when the ternary complex forms, which subunit is limiting, and which phosphosites are erased. The sections below summarize the published framework for this complex and outline CRISPR-based strategies for testing it.

In plain terms, GO:1990630 is the ontology entry for a protein complex made of three parts: IRE1, RACK1 and PP2A. IRE1 is the signal-sensing subunit, RACK1 is the adaptor that holds the other two together, and PP2A is the enzymatic subunit that removes phosphate groups. The QuickGO definition states that RACK1 bridges an interaction between IRE1 and PP2A, which is what makes this a defined ternary complex rather than a coincidental co-localization. Synonyms include ERN1-RACK1-PP2A complex and IRE1alpha-RACK1-PP2A complex, reflecting the gene name ERN1 and the IRE1alpha isoform.

The IRE1-RACK1-PP2A complex is important because it represents a concrete, genetically testable unit that connects an ER-resident stress sensor to a major cellular phosphatase through a defined adaptor. Published work on scaffold-dependent phosphatase complexes, including BAP1-containing assemblies, has demonstrated that the identity of the scaffold determines substrate selection and downstream biological output. Because PP2A activity is pleiotropic, understanding how RACK1 restricts it to IRE1-associated contexts is essential for interpreting signaling data. The complex also sits at the intersection of stress biology and immune or reproductive phenotypes, where inflammasome-related mechanisms have been implicated in male infertility. For translational researchers, GO:1990630 offers a focused annotation to guide CRISPR screens and interaction proteomics rather than broad pathway-level speculation.

The following genes and proteins are the core and functionally related components most relevant to studying GO:1990630, the IRE1-RACK1-PP2A complex.

Regulation of the IRE1-RACK1-PP2A complex is expected to operate at several levels, although the QuickGO definition itself specifies only the composition and bridging relationship. First, availability of the adaptor RACK1 is likely rate-limiting, since adaptor abundance determines how much PP2A can be recruited to IRE1. Second, ER stress conditions that activate IRE1 may alter the probability of complex formation, because IRE1 conformational changes accompany its activation. Third, PP2A activity is itself controlled by regulatory subunits and post-translational modifications, so the complex's output depends on which PP2A holoenzyme is recruited. Comparative studies of scaffold-dependent complexes such as BAP1-containing assemblies show that scaffold identity and modification state can redirect complex function in disease. Finally, parallel ER stress sensors such as PERK and ATF6 provide competing signaling arms that can mask or compensate for complex-specific effects, so regulatory experiments should include controls for these pathways.

Scaffold-dependent phosphatase complexes have emerged as important modifiers of oncogenic signaling, as illustrated by studies of BAP1 complexes in cancer and development. Because the IRE1-RACK1-PP2A complex places PP2A activity under the control of a specific adaptor, its dysregulation could alter the phosphorylation landscape of ER-associated substrates. Cancer models should therefore test whether RACK1 or PP2A subunit loss changes proliferation, stress tolerance or therapy response in isogenic backgrounds.

Inflammasome complex biology has been linked to male infertility, indicating that multi-protein inflammatory assemblies can have reproductive consequences. Given that RACK1 is a known scaffold in immune signaling contexts, the IRE1-RACK1-PP2A complex may intersect with inflammatory pathways, although direct evidence for this specific complex in infertility is not established in the cited literature [2,7]. Researchers should treat this as a hypothesis to be tested with knockout and knock-in models rather than an established mechanism.

The IRE1 arm of the ER stress response is a recognized contributor to diseases of protein folding and secretion, and the IRE1-RACK1-PP2A complex is positioned within that arm. Because PP2A recruitment can attenuate phosphorylation-dependent signaling, loss of the complex could prolong or amplify stress outputs. Disease models should measure canonical IRE1 pathway readouts alongside complex abundance to distinguish direct from indirect effects.

Because GO:1990630 is defined by a physical bridging interaction, co-immunoprecipitation of IRE1 with RACK1 and PP2A subunits is the primary validation method. Proximity-labeling approaches using tagged knock-in alleles can capture transient or low-abundance assemblies that standard co-IP may miss. Controls should include single-subunit knockouts to confirm that the interaction depends on each component.

Since PP2A is a phosphatase, the functional output of the complex is best measured by quantitative phosphoproteomics. Comparing wild-type cells with RACK1 or PP2A knockout cells can reveal substrate phosphosites whose abundance depends on the complex. Data analysis should focus on ER-associated and stress-responsive proteins to prioritize candidates for follow-up.

IRE1 pathway activity can be monitored through downstream transcription factors such as XBP1 and stress-responsive gene programs. Combining transcriptional readouts with complex-abundance measurements helps distinguish direct effects of the complex from compensatory pathway activation. Parallel measurement of PERK and ATF6 arms provides specificity controls.

Fluorescence imaging of tagged subunits can test whether the complex localizes to ER membranes as predicted by the IRE1 anchor. Subcellular fractionation followed by immunoblotting provides an orthogonal measure of localization. These methods are particularly useful when testing point mutations that disrupt bridging without altering protein stability.

Researchers studying IRE1-RACK1-PP2A complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, substrate selection or downstream phenotypes. Answering that question requires clean genetic models in which each subunit can be removed, modified or tagged without confounding artifacts. EDITGENE provides the full set of CRISPR services needed to build such models and to interpret the resulting data.

GO:1990630 defines the IRE1-RACK1-PP2A complex as a specific ternary assembly in which RACK1 bridges IRE1 and PP2A, providing a precise annotation for studies of ER-associated phosphatase signaling. The term is valuable because it converts a broad signaling relationship into a genetically testable unit, enabling knockout, point-mutation, knock-in and overexpression experiments that can assign function to each subunit. Comparative work on other multi-subunit machines reinforces the importance of assembly order and scaffold identity in determining biological output [1,6]. As disease links to scaffold-phosphatase complexes and inflammatory assemblies continue to emerge, rigorous CRISPR-based models will be essential for separating correlation from causation [2,7].